With these virtues, a number of HDAC inhibitors have shown attractive anticancer potential via inducing cancer cell apoptosis [131] and/or cell cycle arrest [132], generating reactive oxygen species (ROS) [133], suppressing angiogenesis and cell invasion [134,135], or increasing immunity response [136]. This evidence concerns the gene HDAC9 and cancer.